Pyonephrosis secondary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 2: Line 2:
{{Pyonephrosis}}
{{Pyonephrosis}}
{{CMG}}; {{AE}} {{HVC}}
{{CMG}}; {{AE}} {{HVC}}
==Overview==
Immediate intravenous antibiotic treatment followed by prompt decompression of the pus is essential to prevent the development of [[septic shock]] and rapid worsening of the patient's condition. Structural changes like [[scarring]], [[fistulas]], and [[abscesses]] may occur if the definitive treatment is delayed after resolution of the infection.
==Secondary prevention==
==Secondary prevention==


* [[Secondary prevention]] includes methods to diagnose and treat an existent disease in early stages before it causes significant morbidity.
*[[Secondary prevention]] includes methods to diagnose and treat existent disease in early stages before it causes significant morbidity.
* Immediate intravenous antibiotic treatment followed by prompt decompression of the pus is essential to prevent development of [[septic shock]] and rapid worsening of the patient's condition. Irreversible damage to the kidney can occur if the treatment is delayed.
*Immediate intravenous antibiotic treatment followed by prompt decompression of the pus is essential to prevent the development of [[septic shock]] and rapid worsening of the patient's condition. Irreversible damage to the kidney can occur if the treatment is delayed.<ref name="pmid6601449">{{cite journal| author=Subramanyam BR, Raghavendra BN, Bosniak MA, Lefleur RS, Rosen RJ, Horii SC| title=Sonography of pyonephrosis: a prospective study. | journal=AJR Am J Roentgenol | year= 1983 | volume= 140 | issue= 5 | pages= 991-3 | pmid=6601449 | doi=10.2214/ajr.140.5.991 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6601449  }} </ref><ref name="pmid27261785">{{cite journal| author=Ludvigson AE, Beaule LT| title=Urologic Emergencies. | journal=Surg Clin North Am | year= 2016 | volume= 96 | issue= 3 | pages= 407-24 | pmid=27261785 | doi=10.1016/j.suc.2016.02.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27261785  }} </ref>
* Structural changes like [[scarring]], [[fistulas]], and [[abscesses]] may occur if the definitive treatment is delayed (e.g., [[urolithiasis]], congenital urological anomaly, tumor).
*Structural changes like [[scarring]], [[fistulas]], and [[abscesses]] may occur if the definitive treatment is delayed (e.g., [[urolithiasis]], congenital urological anomaly, tumor).<ref name="pmid26261472">{{cite journal| author=Simoni F, Vitturi N| title=Sepsis due to pyonephrosis: an adult with pelvic-ureteric junction obstruction (PUJO) in a duplex kidney. | journal=J Ultrasound | year= 2015 | volume= 18 | issue= 3 | pages= 301-4 | pmid=26261472 | doi=10.1007/s40477-014-0104-7 | pmc=4529407 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26261472  }} </ref>


==References==
==References==

Latest revision as of 11:28, 17 October 2021

Pyonephrosis Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pyonephrosis secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pyonephrosis secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pyonephrosis secondary prevention

CDC on Pyonephrosis secondary prevention

Pyonephrosis secondary prevention in the news

Blogs on Pyonephrosis secondary prevention

Directions to Hospitals Treating Pyonephrosis

Risk calculators and risk factors for Pyonephrosis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Harsh Vardhan Chawla, M.B.B.S.[2]

Overview

Immediate intravenous antibiotic treatment followed by prompt decompression of the pus is essential to prevent the development of septic shock and rapid worsening of the patient's condition. Structural changes like scarring, fistulas, and abscesses may occur if the definitive treatment is delayed after resolution of the infection.

Secondary prevention

  • Secondary prevention includes methods to diagnose and treat existent disease in early stages before it causes significant morbidity.
  • Immediate intravenous antibiotic treatment followed by prompt decompression of the pus is essential to prevent the development of septic shock and rapid worsening of the patient's condition. Irreversible damage to the kidney can occur if the treatment is delayed.[1][2]
  • Structural changes like scarring, fistulas, and abscesses may occur if the definitive treatment is delayed (e.g., urolithiasis, congenital urological anomaly, tumor).[3]

References

  1. Subramanyam BR, Raghavendra BN, Bosniak MA, Lefleur RS, Rosen RJ, Horii SC (1983). "Sonography of pyonephrosis: a prospective study". AJR Am J Roentgenol. 140 (5): 991–3. doi:10.2214/ajr.140.5.991. PMID 6601449.
  2. Ludvigson AE, Beaule LT (2016). "Urologic Emergencies". Surg Clin North Am. 96 (3): 407–24. doi:10.1016/j.suc.2016.02.001. PMID 27261785.
  3. Simoni F, Vitturi N (2015). "Sepsis due to pyonephrosis: an adult with pelvic-ureteric junction obstruction (PUJO) in a duplex kidney". J Ultrasound. 18 (3): 301–4. doi:10.1007/s40477-014-0104-7. PMC 4529407. PMID 26261472.

Template:WH Template:WS